IBDEI12D ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17284,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,17285,0)
 ;;=D86.85^^61^785^42
 ;;^UTILITY(U,$J,358.3,17285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17285,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,17285,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,17285,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,17286,0)
 ;;=D86.83^^61^785^40
 ;;^UTILITY(U,$J,358.3,17286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17286,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,17286,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,17286,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,17287,0)
 ;;=D84.1^^61^785^16
 ;;^UTILITY(U,$J,358.3,17287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17287,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,17287,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,17287,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,17288,0)
 ;;=D81.810^^61^785^5
 ;;^UTILITY(U,$J,358.3,17288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17288,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,17288,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,17288,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,17289,0)
 ;;=E88.01^^61^785^2
 ;;^UTILITY(U,$J,358.3,17289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17289,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,17289,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,17289,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,17290,0)
 ;;=J09.X1^^61^785^25
 ;;^UTILITY(U,$J,358.3,17290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17290,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,17290,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,17290,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,17291,0)
 ;;=J09.X2^^61^785^26
 ;;^UTILITY(U,$J,358.3,17291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17291,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,17291,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,17291,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,17292,0)
 ;;=J09.X3^^61^785^27
 ;;^UTILITY(U,$J,358.3,17292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17292,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
 ;;^UTILITY(U,$J,358.3,17292,1,4,0)
 ;;=4^J09.X3
 ;;^UTILITY(U,$J,358.3,17292,2)
 ;;=^5008146
 ;;^UTILITY(U,$J,358.3,17293,0)
 ;;=J09.X9^^61^785^28
 ;;^UTILITY(U,$J,358.3,17293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17293,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
 ;;^UTILITY(U,$J,358.3,17293,1,4,0)
 ;;=4^J09.X9
 ;;^UTILITY(U,$J,358.3,17293,2)
 ;;=^5008147
 ;;^UTILITY(U,$J,358.3,17294,0)
 ;;=J44.9^^61^785^14
 ;;^UTILITY(U,$J,358.3,17294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17294,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,17294,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,17294,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,17295,0)
 ;;=J44.1^^61^785^13
 ;;^UTILITY(U,$J,358.3,17295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17295,1,3,0)
 ;;=3^COPD w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,17295,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,17295,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,17296,0)
 ;;=J42.^^61^785^10
 ;;^UTILITY(U,$J,358.3,17296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17296,1,3,0)
 ;;=3^Bronchitis,Unspec Chronic
 ;;^UTILITY(U,$J,358.3,17296,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,17296,2)
 ;;=^5008234
